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Screening of human fetal brain cDNA library by glioblastoma (GB) and normal human brain total cDNA probes revealed 80
differentially hybridized clones. Hybridization of the DNA from selected clones and the same cDNA probes confirmed this
difference for 38 clones, of which eight clones contained Alu-repeat inserts with increased levels in GB. Thirty clones contained
cDNAs corresponding to mitochondrial genes for ATP synthase subunit 6 (ATP6), cytochrome c oxidase subunit II (COXII),
cytochrome c oxidase subunit III (COXIII), NADH dehydrogenase subunit 1 (ND1), NADH dehydrogenase subunit 4 (ND4),
and mitochondrial 12S rRNA. The levels of all these mitochondrial transcripts were decreased in glioblastomas as compared to
tumor-adjacent histologically normal brain. Earlier we found the same for cytochrome c oxidase subunit I (COXI) Serial
Analysis of Gene Expression (SAGE) showed lower content of the tags for all mitochondrial genes in GB SAGE libraries and
together with our experimental data could serve as evidence of general inactivation of the mitochondrial genome in
glioblastoma—the most malignant and abundant form of human brain tumor.
q 2004 Published by Elsevier Ireland Ltd.
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expression1. Introduction
Malignant gliomas are very aggressive, highly
invasive and neurologically destructive tumors of
the central nervous system. In the most aggressive
manifestation of glioma, glioblastoma (GB), median0304-3835/$ - see front matter q 2004 Published by Elsevier Ireland Ltd
doi:10.1016/j.canlet.2004.07.001
* Corresponding author. Tel.: C380-44-266-3498; fax: C380-
44-266-0759.
E-mail address: kavsan@imbg.org.ua (V. Kavsan).survival ranges from 9 to 12 months despite technical
progress in neurosurgery, chemical, and radiation
therapy. Although a comprehensive view of the genetic
lesions encountered in malignant astrocytic gliomas
has been compiled, present knowledge reflects only a
fraction of the biological mechanisms assumed to
initiate and promote astrocytoma formation. Changes
in gene expression are important determinants of
normal cellular physiology and, if disturbed, directly
contribute to abnormal cellular physiology, includingCancer Letters 218 (2005) 99–107www.elsevier.com/locate/canlet.
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repressed in GB will contribute to our understanding of
the mechanisms underlying tumor initiation and
progression. Knowledge of such mechanisms is likely
to improve diagnostic and prognostic evaluation of
astrocytic gliomas, as well as therapeutic approaches
towards these tumors.
In this study, differential hybridization of human
fetal brain cDNA library with total cDNA probes of GB
and human normal brain was used for the identification
of differentially expressed genes. Hybridization anal-
ysis revealed decreased expression in GB for seven
mitochondrial (mt) genes. Mitochondria are involved
either directly or indirectly in many aspects of
metabolism in cancer cells and notable differences in
the bioenergetics and oxidative metabolism between
normal and transformed cells have been discovered
[1–4]. Differences between the mitochondria of cancer
cells and those of normal cells result in the respiratory
deficiencies common to rapidly growing cancer cells.
The mutations were identified in different mt genes.
The very high frequency of mtDNA mutations and the
increase of mtDNA contents in pancreatic cancer cells
led the authors to speculate that mtDNA may serve as a
diagnostic tool [5]. It is not clear if the increase of
mtDNA mass reflects an increased replication of
mtDNA in response to defective mtDNA function
due to extensive mutations. There is also abundant
evidence for the alteration of the mitochondrial
genome transcription in different cancer cells: in
some tumors and tumor cell lines, transcription of
mitochondrial genes has been shown to occur at a
lower rate than in normal tissue, while in different other
tumors mitochondrial genes express mostly at a higher
level (for example, see reviews of Refs. [6–9]).
Our results extend previous data concerning the
changes of mitochondrial genes expression in tumors
and show general inactivation of the mitochondrial
genome in glioblastoma, the last stage of astrocytic
glioma progression.2. Materials and methods
2.1. Tumor and normal tissue samples
Samples of astrocytic gliomas, WHO grade II and
grade III, GBs and other types of brain tumors wereobtained from the A P. Romodanov Institute of Neuro-
surgery (Kiev). Tumors were classified on the basis of
review of haematoxylin and eosin stained sections of
surgical specimens according to World Health Organi-
zation (WHO) criteria [10]. Surgical specimens of
histologically normal brain tissue adjacent to tumors
were used as a source of normal adult human brain
RNA. Altogether, 41 gliomas and 3 non-glial tumors
were studied. Tumors included 14 GBs (astrocytoma
WHO grade IV), 15 anaplastic astrocytomas (astro-
cytoma WHO grade III), 9 astrocytomas (astrocytoma
WHO grade II), two oligoastrocytoma (WHO grade II),
one anaplastic oligoastrocytoma (WHO grade III), one
epidermoid, one angiosarcoma, and one lymphoma.
2.2. Differential hybridization of cDNA library
Human fetal brain cDNA library (library No 415, 25
week old) was received from the Resource Center/
Primary DataBase (RZPD) of the German Human
Genome Project (Max Planck Institute of Molecular
Genetics, Berlin) The library consists of two filters with
double spotted 27648 cDNA clones on each filter. Total
cDNA probes for differential hybridization were
synthesized from total RNA isolated from surgical
specimens of primary GB and normal adult human
brain. The conditions of oligo(dT)-primed cDNA
synthesis were as described previously [11], but the
concentration of dCTP was reduced to 25 mM and
150–200 mCi of [a-32P]dCTP to obtain cDNA probes
with high specific activity [12]. cDNA filter arrays were
sequentially hybridized with tumor and normal brain
cDNA probes and the coordinates of cDNA clones with
altered hybridization signals between tumor and
control cDNAs were determined on the gridded arrays.
The clones were requested from RZPD (http://www.
rzpd.de) and repeated differential hybridization of these
clones was done.
2.3. RNA isolation and Northern blot analysis
Total RNA was isolated from frozen tissues
according to Chomczynsky and Sacchi [13] RNA
(10 mg per lane) was electrophoretically separated in a
1.5% agarose gel containing 2.2 M formaldehyde and
then transferred to a Hybond-N nylon membrane
(Amersham Pharmacia Biotech, Austria). 32P-labelled
probes of mitochondrial cDNAs were produced with
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membranes were hybridized with 32P-labelled mito-
chondrial cDNA probes in 50% formamide, 5!SSC,
5!Denhardt’s solution, 0.1% SDS and 100 mg/ml
salmon sperm DNA at 42 8C overnight. Extensive
washing was performed: twice with 2!SSC, 0.1% SDS
for 15 min at room temperature; once with 2!SSC,
0.1% SDS for 30 min at 65 8C; and finally with 0.2!SSC,
0.1% SDS for 30 min at 65 8C. Subsequently, the
membranes were exposed to radiographic film with an
intensifying screen at K70 8C. The membranes were
stripped and rehybridized with a 32P-labelled human
b-actin cDNA probe as a control of RNA gel loading.
Densitometric analysis of hybridization signals was
performed by the SCION IMAGE 1.62c program.
2.4. Serial analysis of gene expression (SAGE)
Virtual Northern analysis was carried out for all
mt genes by accessing SAGEmap (NCBI web site
http://www ncbi.nlm.nih.gov/SAGE). Five GB SAGE




SAGE_Brain_glioblastoma_B_R70) and two normal
human brain SAGE libraries (GSM676:
SAGE_BB542_whitematter and GSM763: SAGE_
normal_pool(6th)) were selected for the displaying of
the differences of mt genes expression.Fig. 1. Differential hybridization of plasmid DNAs with total3. Results3.1. Identification of genes with altered expression
in GBs by differential hybridization
Hybridization of an arrayed human fetal brain
cDNA library with total cDNA probes of GB
and normal human adult brain revealed about one
hundred cDNA clones with differences in the intensity
of hybridization. Plasmid DNA from 80 cDNA clones
received from RZPD was digested by HindIII/EcoRI
restriction endonucleases, and after electrophoresis
was blotted and hybridized with the same cDNA
probes. Repeated differential hybridization of selected
cDNA clones confirmed the results of the primary
screening for 38 clones. Differential hybridization of
one such plasmid DNA blot is shown in Fig. 1 where is
possible to see that some cDNA inserts (lanes 10, 26)
hybridized more intensive with a GB cDNA probe
while the majority (lanes 1,5,9,15,16,19,24,25,28)
hybridized more intensive with the normal adult
human brain cDNA probe.
Nucleotide sequence analysis of cDNA inserts
from 38 clones revealed 8 clones containing Alu-
repeats and 30 clones with cDNAs corresponding to
mitochondrial genes ATP6, COXI, COXII, COXIII,
ND1, ND4, and 12S rRNA (Table 1).
As it was expected in accordance with the results
of primary screening, Alu-containing sequencescDNA probes of human normal brain (A) and GB (B).
Table 1





DKFZp415A2296 decreased mt NADH dehydrogenase subunit 1
DKFZp415D11116 decreased mt NADH dehydrogenase subunit 1
DKFZp415J1098 decreased mt NADH dehydrogenase subunit 1
DKFZp415L2318 decreased mt NADH dehydrogenase subunit 1
DKFZp415N0897 decreased mt NADH dehydrogenase subunit 1
DKFZp415N1579 decreased mt NADH dehydrogenase subunit 1
DKFZp415?1316 decreased mt NADH dehydrogenase subunit 4
DKFZp415G18136 decreased mt NADH dehydrogenase subunit 4
DKFZp415M02136 decreased mt NADH dehydrogenase subunit 4
DKFZp415P2074 decreased mt cytochrome oxidase subunit I
DKFZp415G06136 decreased mt cytochrome oxidase subunit II
DKFZp415E117 decreased mt cytochrome oxidase subunit III
DKFZp415E1874 decreased mt cytochrome oxidase subunit III
DKFZp415E1386 decreased mt cytochrome oxidase subunit III
DKFZp415I1555 decreased mt cytochrome oxidase subunit III
DKFZp415J19138 decreased mt cytochrome oxidase subunit III
DKFZp415K05112 decreased mt cytochrome oxidase subunit III
DKFZp415K1124 decreased mt cytochrome oxidase subunit III
DKFZp415L07128 decreased mt cytochrome oxidase subunit III
DKFZp415 decreased mt cytochrome oxidase subunit III
N2116DKFZp415P2330 decreased mt cytochrome oxidase subunit III
DKFZp415H0983 decreased mt ATP synthase subunit 6
DKFZp415J0588 decreased mt ATP synthase subunit 6
DKFZp415H20103 decreased mt ATP synthase subunit 6
DKFZp415I0891 decreased mt ATP synthase subunit 6
DKFZp415K0676 decreased mt ATP synthase subunit 6
DKFZp415L24135 decreased mt ATP synthase subunit 6
DKFZp415N0519 decreased mt ATP synthase subunit 6
DKFZp415N0413 decreased mt ATP synthase subunit 6
DKFZp415E0479 decreased mt 12S rRNA
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total cDNA.3.2. Northern analysis of mt genes expression
in astrocytic gliomas
Regardless of the type or combination of data for
genes with altered expression in glioblastoma versus
normal brain, there is still a need to confirm and
expand the expression information Northern blot
hybridization seems to be the best approach for this
purpose. Indeed, Northern analysis of astrocytic
gliomas of different malignancy grades showed the
significantly lower level of ATP6, COXIII, COXII
and ND1 mRNAs in GB (sample 182) as compared to
normal brain (sample 181) of the same patient(Fig. 2). These tissue samples were used for primary
screening of the human fetal brain cDNA library.
Mean values of ATP6, COXIII, COXII or ND1
mRNA content in GBs was about two fold lower than
in normal brain. It varied greatly in different GB
samples analyzed that likely reflected the molecular
heterogeneity of these tumors.
The comparison of the pairs of astrocytic tumors
and corresponding adjacent tissues of normal brain
showed the difference in the mt mRNAs level for
anaplastic astrocytoma (Fig. 2A–D, lanes 21 and 22)
and even for astrocytoma grade II (Fig. 2A–D, lanes
19 and 20).
Northern hybridization with COXI (Fig. 3) and
with ND4-probes (Fig. 4) showed similar patterns of
the expression in normal brain and astrocytic tumors.
Fig. 2. Expression of ATP6, COX III, COXII and ND1 genes in normal human tissues and in brain tumors. Northern blot hybridization of
32P-labeled ATP6 (A), COXIII (B), COXII (C) and ND1 (D) cDNA probes with tumor RNA panel. Tissue types and tumor subtypes are
indicated above each lane of the blot: FB, human fetal brain; RB, rat brain; NB, human normal brain; GB, glioblastoma; AA, anaplastic
astrocytoma; A, astrocytoma; L, lymphoma. (E) Northern blot hybridization of the same blot with b-actin cDNA control probe. (F)
Ethidium bromide stained agarose gel. (G) Bar graphs showing relative expression of mt genes after correction for gel loading based on
b-actin gene expression.
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Fig. 3. Expression of COXI gene in normal human tissues and in brain tumors. (A) Northern blot hybridization of 32P-labeled COXI cDNA
probe with tumor RNA panel. Tissue types and tumor subtypes are indicated above each lane of the blot: He, human heart; K, human kidney;
NB, human normal brain; GB, glioblastoma; AA, anaplastic astrocytoma; A, astrocytoma; OA, oligoastrocytoma; Ans, angiosarcoma; Ep,
epidermoid; FB, human fetal brain; RB, rat brain. (B) Northern blot hybridization of the same blot with b-actin cDNA control probe.
(C) Ethidium bromide stained agarose gel. (D) Bar graphs showing relative expression of COXI gene after correction for gel loading based on
b-actin gene expression.
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these mRNAs in GB as compared to normal brain
samples.
3.3. Analysis of the expression of mt genome in GB
and normal brain by SAGE
Tag counts of all mt genes were examined in
astrocytic gliomas and normal brain by accessing
SAGEmap In the description to SAGE (http://www.
ncbi.nlm.nih.gov/SAGE/) are some caviates that mt
sequences were in large part masked or removed from
Unigene but not from mapping of tags to mitochon-
drial sequences. A single NlaIII tag was revealed for
each of the mt genes by utilizing the ‘Retrieve by
sequence’ option, and expression of all mt genes
in astrocytic gliomas was analyzed by ‘Virtual North-
ern’. Thus, we obtained clear evidence that transcrip-
tion levels of all mitochondrial genes are lower inglioblastoma than in the human normal brain
(Table 2).4. Discussion
Mitochondrial defects have long been suspected to
play an important role in the development and
progression of cancer. Several distinct differences
between the mitochondria of cancer cells and normal
cells have already been observed at the genetic,
molecular and biochemical levels and these studies
have indicated that mitochondrial dysfunction is
involved in carcinogenesis. In particular, activation
of the genes for COXI, COXII, and 16S rRNA was
shown in rat fibroblast cells immortalized or trans-
formed by viral and cellular oncogenes [14]; ND5,
ND6, cytochrome b, COXII, and 16S rRNA in
chemically induced rat hepatomas [15]; ND1, 12S
Fig. 4. Expression of ND4 gene in normal human tissues and in brain tumors. (A) Northern blot hybridization of 32P-labeled ND4 cDNA probe
with tumor RNA panel. Tissue types and tumor subtypes are indicated above each lane of the blot: NB, human normal brain; GB, glioblastoma;
AA, anaplastic astrocytoma; A, astrocytoma; AOA, anaplastic oligoastrocytoma. (B) Northern blot hybridization of the same blot with b-actin
cDNA control probe. (C) Ethidium bromide stained agarose gel. (D) Bar graphs showing relative expression of ND4 gene after correction for gel
loading based on b-actin gene expression.
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coli patients [16]. Elevated levels of ATP6, ND5,
cytochrome b, COXI, and COXII mRNAs were
revealed in papillary thyroid carcinomas as compared
to normal thyroid tissue [17]. Sharp et al. [18]
detected activation of the COXII gene by analysis of
17 breast cancer tumors, but failed to detect the
alterations in ATP6, ND2 and ND4 gene expression.
Other mitochondrial enzyme levels (NADH cyto-
chrome c reductase, succinate cytochrome c
reductase, and cytochrome c oxidase) have been
shown to change also during exposure to carcinogens
with cytochrome c oxidase levels remaining elevated
even after discontinuation of exposure [19]; increased
levels of RNA transcripts of the nuclear-encoded
subunit COXIV and mitochondrially encoded COX
subunits I and II have been observed in Zajdela
hepatoma as compared with normal liver [20]. A
study utilizing tissues from 15 colorectal cancerpatients found that ND2 mRNA levels were elevated
in the malignant tissue as compared to normal tissue
from the same individuals [21]. Analysis of the
mitochondrial genome in colorectal cancer cell lines
also revealed abnormalities; elevated expression of
16S rRNA, ND4, ND4L, cytochrome b, COXII,
ATP6, and ATP8 was detected in the HT-29 cell
line [22]. ND1, ND4, and COXII genes were shown to
be overexpressed in B-cell non-Hodgkin’s lympho-
mas in SIV-infected monkeys, 16S rRNA, COXII,
ATP6, cytochrome b, ND2, and ND4—in human
lymphomas [23].
In contrast to the investigations cited earlier, Zhou
et al. [24] found that mitochondrial cytochrome c
oxidase (COX) activity was significantly diminished
in p53(K/K) cells. Their study suggests that p53 is
involved in regulation of COXII at the protein level
but not at the mRNA level. Decrease in COX activity
was found also when comparing the specific activity
Table 2
Results of ‘Virtual Northern’ of mt genes















GTAAGTGTAC 664 727 28 145 238 820 151 12S rRNA
CTAAGACTTC 16864 10489 1983 3651 2773 3156 3239 16S rRNA
CACCTAATTG 9053 11739 2282 4314 2554 7153 15600 ATP6/ ATP8
CACTACTCAC 1443 1439 570 646 0 1915 2875 Cytochrome b
ATTTGAGAAG 4163 6992 2297 2165 556 2804 1261 COXI
CCCATCGTCC 11267 14001 4879 10616 4701 3107 17810 COXII
TGATTTCACT 4279 4176 1383 1276 735 2413 5328 COXIII
ACCCTTGGCC 6840 8748 870 1842 79 1847 2260 ND1
ACTAACACCC 6861 5505 784 1939 864 2609 2230 ND2
AGCCCTACAA 8621 8574 1169 3571 2713 5404 6518 ND3
TTCATACACC 5354 4002 3167 3183 7514 2756 14964 ND4/ ND4L
AGACCCACAA 653 648 99 226 188 263 988 ND5
GGGGTCAGGG 242 221 57 145 79 107 191 ND6
SAGE libraries (total tag counts in library indicated in parentheses): A*, GSM676: SAGE_ BB542_ white matter; B*, GSM763: SAGE_ normal
pool (6th); C*, GSM696: SAGE_Duke_GBM_H1110; D*, GSM765: SAGE_ pooled_GBM; E*, GSM14767: SAGE_Brain_glioblasto-
ma_B_H833; F*, GSM 14768: SAGE_Brain_glioblastoma_B_R336; G*, GSM14769: SAGE_Brain_glioblastoma_B_R70.
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adenocarcinoma versus normal colon mucosa [25],
in cultured rat HC252 hepatoma cells versus non-
neoplastic liver [26], and in cultured carcinoma cell
lines MCF-7 (breast), T47D (breast) and DU-145
(prostate) versus normal epithelial cells [27]. Faure-
Vigny et al. [28] detected the lower expression of
several mitochondrial genes encoding the proteins
involved in energy metabolism of cancer cells in renal
tumors of different types: a clear cell carcinoma, an
oncocytoma, and urothelial tumors. The mean level of
expression of COX subunit III gene was found to be
lower in carcinoma versus normal mucosa samples
[29]. A separate study reported the loss of mtDNA and
mRNA coding for subunit the ND3 gene in renal cell
carcinoma [30].
Our results obtained by differential hybridization
of arrayed human fetal brain cDNA library with GB
and normal adult brain cDNA probes with subsequent
sequence analysis of differentially hybridized cDNAs,
Northern blot hybridization, and SAGE, revealed
decreased expression of all mitochondrial genes in
glioblastoma as compared to human normal adult
brain. These results suppose possible coordinated
changes of mitochondrial genes expression in GB.
The reason of the decrease of mt mRNA levels is not
known yet; it may be a consequence of the decrease ofmt genome transcription activity, the increase of large
mutations in mitochondrial DNA, or/and the decrease
of quantity of mitochondria in glioblastomas. Dis-
crepancies in the results concerning increase or
decrease of the expression of mt genes in different
tumors may be due to the different nature of various
cancer types under investigation, and the reduction of
all mt mRNA levels in GB may reflect the
peculiarities of glioblastoma, the last grade of
astrocytic glioma progression.Acknowledgements
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